Engineered NK Cells Target CD73 to Attack Hard-to-Treat Lung Adenocarcinoma
Preclinical research shows that natural killer cells engineered with a CD73-targeting receptor kill relapsed or refractory lung adenocarcinoma cells in ...
Tag: CD73
GMP-Compliant Platform Turns Wharton’s Jelly Stem Cells Into Clinical-Grade Extracellular Vesicles
Researchers have built and validated a GMP-compliant, semi-automated manufacturing platform that produces clinical-grade extracellular vesicles from Wharton's jelly-derived mesenchymal stromal ...
CD73 and VEGF in Vietnamese Salivary Cancers
Salivary gland carcinomas, though rare, represent a complex oncological challenge due to their heterogeneous histology and often poor outcomes, particularly ...
POPULAR NEWS
-
Modeling Reveals How Silica Gold Nanoparticles Reshape Optical Energy and Fields
-
Intravenous Iron Formulations Spur Divergent Muscle Recovery in Iron Deficiency Anaemia
-
Pararectal Leiomyosarcoma Diagnosed After Laparoscopic Hysterectomy Without Morcellation
-
Bone and Soft Tissue Combined: New Imaging Method Builds 3D Shape Models of the Foot and Ankle